Argenx
ARGX
#404
Rank
C$86.21 B
Marketcap
C$1,386
Share price
-0.55%
Change (1 day)
35.92%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): C$22.07

According to Argenx 's latest financial reports the company's current EPS (TTM) is C$22.13. In 2025 the company made an earnings per share (EPS) of C$29.51 an increase over its 2024 EPS that were of C$19.49.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$22.07-25.21%
2025C$29.5151.44%
2024C$19.49-369.77%
2023C-$7.22-60.46%
2022C-$18.2763.33%
2021C-$11.18-40.37%
2020C-$18.76183.47%
2019C-$6.62123.09%
2018C-$2.9754.93%
2017C-$1.9114.07%
2016C-$1.6813.05%
2015C-$1.48-36.34%
2014C-$2.33209.04%
2013C-$0.75-33.99%
2012C-$1.14185.59%
2011C-$0.40